Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Cohort Study of Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus

NCT06527482 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06527482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Cohort Study of Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2023
Completion date
September 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autologous osteoperiosteal transplantation, osteochondral lesion of talus